Year: 2019

캐나다 워털루, Nov. 26, 2019 (GLOBE NEWSWIRE) — Teledyne Technologies[NYSE:TDY] 회사이자 전 세계 머신 비전 기술을 선도하는 Teledyne DALSA는 최신 충전식 CMOS TDI 카메라인 Linea HS 16k Multifield TDI 카메라의 출시를 발표했다. 멀티필드 이미징을 사용하면 최종 사용자가 1회 스캔으로 명시야, 암시야 및 배면광 이미지 등 여러 이미지를 캡처하는 것이 가능하다.다중 배열 TDI 센서 아키텍처를 기반으로 하는 신형 16k 카메라는 평면 패널 디스플레이, PCB 및 웨이퍼 검사, 생명과학, 항공 이미지 및 웹 검사와 같은 고성능 이미징 응용 분야에 필요한 100kHz x 3 라인율 또는 초당 5GPix 속도의 데이터 처리량을 제공한다.Linea HS 16k Multifield 카메라는 업계 최초로 스펙트럼 간섭이 최소화된 통합 다이크로익 필터를 사용하여 최대 3개의 필드 이미지(예: 명시야, 암시야 및 배면광)를 1회 스캔으로 스펙트럼을 분리하고 캡처하는 기능을 제공한다. 고급 조명과 함께 사용하는 경우 멀티필드는 택트 타임과 추적 가능성을 대폭 향상한다.Teledyne DALSA 라인 스캔 제품군의 선임 제품 관리자 Xing-Fei He는 “OLED 디스플레이 자동 광학 검사(AOI)와 같은 까다로운 응용 분야의 경우, 현재 최종 사용자는 결함을 감지하기 위해 다양한 조명 조건에서 여러 차례 스캔을 수행해야 합니다. 신형 Linea HS Multifield 카메라를 사용하면 3회의 별도 패스가 필요했던 작업을 1회 스캔으로 완료할 수 있습니다.   이를 통해 AOI 시스템의 데이터 처리량이...

VANCOUVER, British Columbia, Nov. 26, 2019 (GLOBE NEWSWIRE) — Aben Resources Ltd. (TSX-V: ABN) (OTCQB: ABNAF) (Frankfurt: E2L2) (“Aben” or “the Company”) has received and interpreted analytical results from the final seven drill holes (FK19-64 to 70) of the 2019 drill exploration program conducted at the Forrest Kerr Gold Project in the Golden Triangle region of British Columbia. Five of these drill holes were collared in the far south of the Boundary Valley with two holes completed at the Forrest prospect, located 14 km SSW from Boundary. The second and final phase of drilling in 2019 tested for precious and base-metal mineralization associated with structures and along geologic contacts located outboard from known mineralization toward the margins of the large hydrothermal system present on this part of the Forrest Kerr Property.Forrest...

NEW YORK, Nov. 26, 2019 (GLOBE NEWSWIRE) — MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading platform for fixed-income securities, and the provider of market data and post-trade services for the global fixed-income markets, today announced that Tony DeLise, Chief Financial Officer, is scheduled to speak at the 41st Nasdaq Investor Conference in London at 6:45 a.m. EST / 11:45am GMT on December 3, 2019.The presentation will be broadcast live on the internet. Listeners will be able to access it through the link at: https://edge.media-server.com/mmc/p/6arvvpi9About MarketAxessMarketAxess operates a leading, institutional electronic trading platform delivering expanded liquidity opportunities, improved execution quality and significant cost savings across global fixed-income markets. A record $1.7...

BOULDER, Colo., Nov. 26, 2019 (GLOBE NEWSWIRE) — miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, today announced that management will be presenting at the Evercore ISI HealthCONx Conference 2019 on Tuesday, December  3rd,  taking place at the Four Seasons Hotel in Boston, Massachusetts.           About miRagen TherapeuticsmiRagen Therapeutics, Inc. is a clinical-stage biopharmaceutical company discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high unmet medical need. miRagen has three clinical stage product candidates, cobomarsen, remlarsen, and MRG-110. miRagen’s clinical product candidate for the treatment of certain cancers,...

EMERYVILLE, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) — Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that Andrew Allen, M.D., Ph.D., co-founder, president and chief executive officer, will present a company overview on Tuesday, December 3, 2019 at 8:30 a.m. ET during the Piper Jaffray 31st Annual Healthcare Conference in New York.A live audio webcast will be available within the Investors & Media section of the Gritstone Oncology website at https://ir.gritstoneoncology.com/investors/events. An archived replay will be accessible for 30 days following the event.About Gritstone Oncology Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of cancer...

TORONTO, Nov. 26, 2019 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a medical device license issued by Health Canada and CE Mark from DEKRA Certification B.V. to market Venus Epileve. It is intended as a treatment for hirsutism, permanent hair reduction and pseudofolliculitis barbae in Europe, and for hair removal, permanent hair reduction, and the treatment of pseudofolliculitis barbae in Canada.Venus Epileve represents a new product introduction that expands the Company’s diode laser hair removal offering beyond the Venus Velocity which was introduced to the medical aesthetics market in 2017. The Venus Epileve is cost-effective, fast, comfortable, and can be used on all skin types (Fitzpatrick skin types...

CAMBRIDGE, Mass. and BEIJING, China, Nov. 26, 2019 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, today announced that the company will present at the 31st Annual Piper Jaffray Healthcare Conference in New York, NY. The presentation is scheduled for 9:30 a.m. ET on Tuesday, December 3, 2019.A live webcast can be accessed from the investors section of BeiGene’s website at http://ir.beigene.com/. An archived replay will be available for 90 days following the event.About BeiGeneBeiGene is a global, commercial-stage, research-based biotechnology company focused on molecularly-targeted and immuno-oncology cancer therapeutics. With a team of over 3,000...